Schizophrenia Research
Volume 47, Issue 1 , Pages 99-103 , 15 January 2001

Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia

Received 1 May 1999 ,Accepted 10 December 1999.

References 

  1. Deakin JFW, Slater P, Simpson MDC, Gilchrist AC, Skan WJ, Royston MC, et al. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 1989;52(6):1781–1786
  2. Domino EF, Luby ED. Abnormal mental states induced by phencyclidine as a model of schizophrenia. In:  Domino EF editors. PCP (Phencyclidine): Historical and Current Perspectives. Ann Arbor, MI: NPP Books; 1981;p. 173–183
  3. Farmer AE, McGuffin P, Gottesman II. Twin concordance for DSM-III schizophrenia — scrutinizing the validity of the definition. Arch. Gen. Psychiatry. 1987;44(7):634–641
  4. Freedman R, Coon H, MylesWorsley M, OrrUrtreger A, Olincy A, Davis A, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. USA. 1997;94(2):587–592
  5. Goodwin H, Curran N, Chioza B, Blower J, Nashef L, Asherson P, et al. No association found between polymorphisms in genes encoding mGluR7 and mGluR8 and idiopathic generalised epilepsy in a case control study. Epilepsy Res. (39), 2000;41–47
  6. Gottesman II, Shields J. Schizophrenia, the Epigenetic Puzzle. Cambridge: Cambridge University Press; 1982;
  7. Gottesman II. Schizophrenia Genesis. New York: W.H. Freeman and Company; 1991;
  8. Harrison PJ, McLaughlin D, Kerwin RW. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet. 1991;337(8739):450–452
  9. Kerwin R, Patel S, Meldrum B. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain postmortem. Neuroscience. 1990;39(1):25–32
  10. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 1980;20(3):379–382
  11. Kornhuber J, Mackburkhardt F, Riederer P, Hebenstreit GF, Reynolds GP, Andrews HB, et al. [H-3]MK-801 binding-sites in postmortem brain regions of schizophrenic patients. J. Neur. Transm. 1989;77(2–3):231–236
  12. Makoff A, Pilling C, Harrington K, Emson P. Human metabotropic glutamate receptor type 7: molecular cloning and mRNA distribution in the CNS. Mol. Brain Res. 1996;40:165–170
  13. Ohishi H, Akazawa C, Shigemoto R, Nakanishi S, Mizuno N. Distributions of the Messenger-RNAs for l-2-Amino-4- phosphonobutyrate-sensitive metabotropic glutamate receptors mGluR4 and mGluR7 in the rat-brain. J. Comp. Neurol. 1995;360(4):555–570
  14. Pin J-P, Duvoisin R. Metabotropic glutamate receptors I. The metabotropic glutamate receptors: Structure and functions. Neuropharmacology. 1995;34(1):1–26
  15. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273(5281):1516–1517
  16. Shaw SH, Kelly M, Smith AB, Shields G, Hopkins PJ, Loftus J, et al. A genome-wide search for schizophrenia susceptibility genes. Am. J. Med. Genet. 1998;81(5):364–376
  17. Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, et al. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci. 1997;17(19):7503–7522
  18. Takahashi K, Tsuchida K, Tanabe Y, Masu M, Nakanishi S. Role of the large extracellular domain of the metabotropic glutamate receptors in agonist selectivity determination. J. Biol. Chem. 1993;268:19341–19345

PII: S0920-9964(99)00235-2

Schizophrenia Research
Volume 47, Issue 1 , Pages 99-103 , 15 January 2001

Article Tools